XBiotech Competitors and Similar CompaniesClear all
Aptinyx's competitors and similar companies include RAPT Therapeutics.
 Aptinyx Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders. |  RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. | |
Founding Date | Founding Date 2015 | Founding Date 2015 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Evanston, US HQ Evanston, US | Locations South San Francisco, US HQ |
Employees | Employees 635% increase | Employees 64 |
Valuation ($) | Valuation ($) 4.1 m | Valuation ($) 69.8 m |
Financial | ||
Net income | Net income ($64.8m) (FY, 2022) | Net income ($129.9m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 135m | Total funding raised $ 176m |
For sources of this data, please see the company profile
View Company Profiles
RAPT Therapeutics
HQ
South San Francisco, US
Employees
64
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View company